What is the appropriate evaluation and management for a patient presenting with epistaxis, considering their medical history and potential underlying conditions?

Evaluation and Management of Epistaxis

Immediate First-Line Management

The single most important intervention is firm, continuous compression of the soft lower third of the nose for a full 10-15 minutes without interruption, with the patient sitting upright and head tilted slightly forward. 1

Initial Positioning and Compression

• Position the patient sitting upright with head tilted slightly forward to prevent blood from entering the airway or stomach 1
• Have the patient breathe through their mouth and spit out blood rather than swallowing it 1
• Apply firm, continuous pressure by pinching the soft lower third of the nose for at least 10-15 minutes without checking if bleeding has stopped—premature release is the most common error leading to treatment failure 1
• Compression alone resolves the vast majority of anterior epistaxis cases 1

Critical Triage Assessment During Initial Management

• Assess bleeding duration: >30 minutes suggests moderate-to-severe epistaxis requiring immediate intervention 1
• Check for hemodynamic instability: tachycardia, syncope, orthostatic hypotension, dizziness, or weakness 1
• Bleeding from both nostrils or mouth suggests posterior source requiring urgent care 1
• Document risk factors: anticoagulant/antiplatelet use, bleeding disorders, recent nasal trauma, prior nasal surgery, intranasal drug use 1

Common Pitfall: Do NOT apply ice packs—current evidence does not support their use as they do not significantly change nasal blood flow 1

---

Second-Line Treatment: Topical Vasoconstrictors

If bleeding persists after 10-15 minutes of proper compression:

• Clean the nasal cavity of blood clots by suction or gentle nose blowing 1
• Apply topical vasoconstrictor spray (oxymetazoline or phenylephrine) 2 sprays into the bleeding nostril 1
• Resume firm compression for another 5-10 minutes after applying the vasoconstrictor 1
• This approach stops bleeding in 65-75% of cases that don't respond to compression alone 1, 2

Caution: Vasoconstrictors may be associated with increased risk of cardiac or systemic complications in susceptible patients 1

---

Third-Line Treatment: Visualization and Cauterization

If bleeding continues despite compression and vasoconstrictors:

Anterior Rhinoscopy

• Perform anterior rhinoscopy to identify the bleeding source after clot removal 1
• Most epistaxis (>90%) originates from the anterior septum (Kiesselbach's plexus) 1

Cauterization Technique

• Electrocautery is superior to chemical cauterization with fewer recurrences (14.5% vs. 35.1%) 1, 2
• Apply topical anesthetic (lidocaine or tetracaine) before cauterization 1
• Restrict cautery application only to the active bleeding site 1
• Critical Warning: Avoid bilateral simultaneous septal cautery as it increases risk of septal perforation 1

Nasal Endoscopy

• Indicated if anterior rhinoscopy fails to identify the source or if recurrent bleeding occurs despite prior treatment 1
• Localizes the bleeding site in 87-93% of cases 1
• Particularly important in elderly patients who may have unrecognized pathology 1

---

Fourth-Line Treatment: Nasal Packing

Nasal packing is indicated when:

• Bleeding continues despite 15-30 minutes of proper compression with vasoconstrictors 1
• Life-threatening bleeding is present 1
• Posterior bleeding source is suspected 1

Packing Material Selection

• For patients on anticoagulants or antiplatelet medications: Use ONLY resorbable/absorbable packing materials (Nasopore, Surgicel, Floseal) to reduce trauma during removal 1
• For patients without bleeding risk factors: Either resorbable or non-resorbable materials may be used 1
• Newer hemostatic materials (hemostatic gauzes, thrombin matrix, gelatin sponge, fibrin glue) are more effective with fewer complications 2

Posterior Epistaxis Management

• Posterior epistaxis (5-10% of cases) is more common in older patients, more difficult to control, and has higher likelihood of requiring hospitalization 3
• Posterior nasal packing with Foley catheter and tranexamic acid-soaked gauze may be indicated 1
• Tranexamic acid promotes hemostasis in 78% of patients versus 35% with oxymetazoline and 31% with nasal packing alone 2

---

Advanced Interventions for Refractory Bleeding

Surgical Options

• Endoscopic sphenopalatine artery ligation has a 97% success rate, significantly outperforming conventional packing (62% success rate) 1, 2
• Endoscopic cauterization is more effective than ligation 2
• Recurrence rates: <10% for surgical ligation or embolization versus 50% for nasal packing 1

Endovascular Embolization

• 80% success rate with recurrence rates <10% 1, 2
• Comparable efficacy and complications to surgical methods 2
• Uses gelatin sponge, foam, PVA, and coils 2

Indications for Advanced Intervention

• Persistent or recurrent bleeding not controlled by packing or cautery 1
• Refractory posterior epistaxis 1

---

Special Population Considerations

Anticoagulated Patients

• Do NOT reverse anticoagulation in hemodynamically stable patients with controlled bleeding using local measures 1
• For warfarin patients: Check INR to evaluate therapeutic range; supratherapeutic levels may require specialty consultation or reversal agents for severe refractory bleeding 3
• Decision to restart anticoagulation should balance thrombosis and bleeding risk, typically within 24-48 hours after confirmed hemostasis 1

NSAID Users

• Continue NSAIDs despite epistaxis unless bleeding cannot be controlled with local measures 1
• For aspirin in high-risk cardiovascular patients: Continue despite epistaxis as survival benefits outweigh bleeding risks 1
• Critical Warning: Premature NSAID discontinuation should be avoided as most epistaxis resolves with local measures alone 1

Hypertensive Patients

• Do NOT routinely lower blood pressure acutely during active epistaxis—excessive reduction can cause or worsen renal, cerebral, or coronary ischemia 3
• Monitor blood pressure but base control decisions on bleeding severity, individual comorbidities, and risks of blood pressure reduction 3

Pediatric Patients (Age 3+)

• Same compression technique: 10-15 minutes of continuous pressure 4
• Topical vasoconstrictors if compression fails 4
• Silver nitrate cautery is preferred over electrocautery in children 4
• Only 6.9% of pediatric cases require procedures beyond compression and topical agents 4

---

Prevention of Recurrence

• Apply petroleum jelly or other moisturizing/lubricating agents to the anterior nasal septum 1, 4
• Regular use of saline nasal sprays to keep nasal mucosa moist 1, 4
• Use humidifiers in dry environments 1
• Avoid nasal manipulation, vigorous nose-blowing, and nasal decongestants for at least 7-10 days after treatment 1

---

Red Flags Requiring Specialist Referral

Immediate ENT Consultation Needed

• Hemodynamic instability despite initial management 1
• Posterior epistaxis requiring posterior packing 5
• Recurrent bleeding despite appropriate treatment 1
• Inability to identify bleeding source 1

Concerning Features Requiring Further Investigation

• Unilateral epistaxis with nasal obstruction, facial pain, or visual changes (suggests possible tumor) 3
• Recurrent bilateral nosebleeds or family history of recurrent nosebleeds (assess for hereditary hemorrhagic telangiectasia) 1
• Nasal and oral mucosal telangiectasias 1
• Ineffective treatments or recurrent bleeding suggesting underlying conditions 3

---

Post-Treatment Follow-Up

• Arrange follow-up within 30 days to assess outcome and complications 1
• Document outcomes to improve individual patient care and provide research opportunities 1
• Educate patients on signs requiring additional follow-up: recurrent bleeding, signs of infection, or secondary symptoms 1
• Adequate follow-up allows assessment for underlying conditions when treatments are ineffective 1